• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Simon Sturge - Articles and news items

Boehringer Ingelheim logo

Boehringer Ingelheim and Apexigen sign manufacturing agreement

Industry news, News / 5 December 2012 / Boehringer Ingelheim

“We are very pleased to partner with Apexigen…”

Boehringer Ingelheim logo

Boehringer Ingelheim enters strategic collaboration agreement

Industry news, News / 12 November 2012 / Boehringer Ingelheim

Boehringer Ingelheim and Molecular Partners have entered into a strategic manufacturing collaboration…

Boehringer Ingelheim logo

Boehringer Ingelheim Biopharmaceuticals announces manufacturing agreement with Servier

Industry news, News / 3 August 2012 / Boehringer Ingelheim

Boehringer Ingelheim announced an agreement with Servier & its partner XOMA Corporation…

Boehringer Ingelheim logo

Boehringer Ingelheim BioXcellence

Industry news, News / 18 June 2012 / Boehringer Ingelheim

Boehringer Ingelheim BioXcellence: Distinctive brand for the biopharmaceutical contract manufacturing business…

Boehringer Ingelheim logo

Boehringer Ingelheim and Xencor enter a collaboration agreement

Industry news, News / 21 February 2012 / Boehringer Ingelheim

Antibodies engineered with Xencor’s proprietary Xtend™ technology for increasing antibody half-life…

Boehringer Ingelheim logo

Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply

Industry news, News / 26 January 2012 / Boehringer Ingelheim

Boehringer Ingelheim has expanded its biopharmaceutical cell line development services…

Boehringer Ingelheim logo

Boehringer Ingelheim wins Frost & Sullivan Award

Industry news, News / 7 September 2011 / Boehringer Ingelheim

Boehringer Ingelheim wins the ‘2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award’…

Boehringer Ingelheim logo

Boehringer Ingelheim licenses ProBioGen’s novel GlymaxX® technology

Industry news, News / 10 August 2011 / Boehringer Ingelheim

Boehringer Ingelheim and ProBioGen AG have signed a non-exclusive Licensing Agreement regarding ProBioGen’s GlymaxX® technology…

Boehringer Ingelheim logo

Boehringer Ingelheim extends “one stop shop” service

Industry news, News / 20 June 2011 / Boehringer Ingelheim

Boehringer Ingelheim is expanding its capacities and capabilities in fill & finish for biopharmaceuticals…

Simon Sturge

Boehringer Ingelheim finalizes acquisition of AMGEN’s Fremont facility in the USA

Industry news, News / 25 March 2011 / Boehringer Ingelheim

Yesterday Boehringer Ingelheim formally acquired Amgen’s biopharmaceutical development and manufacturing facility in Fremont, California (USA)…

elan

Elan and Boehringer Ingelheim announce agreement for antibody-based therapeutics

Industry news, News / 9 February 2011 / Boehringer Ingelheim

Announcement covers global technical development and manufacturing for antibody-based therapeutics…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +